MedPage Today  Oct 2  Comment 
(MedPage Today) -- The novel anticoagulant apixaban reduces the risk of stroke and major bleeding among patients with atrial fibrillation, regardless of baseline risk, a secondary analysis of the ARISTOTLE trial showed.
Benzinga  Oct 2  Comment 
Bristol-Myers Squibb NYSE: BMY) and Pfizer (NYSE: PFE) today announced that the reductions in stroke or systemic embolism, major bleeding and mortality demonstrated with ELIQUIS® compared to warfarin in the ARISTOTLE trial...
MedPage Today  Aug 29  Comment 
MUNICH (MedPage Today) -- The novel anticoagulant apixaban is better than warfarin at preventing stroke and reducing mortality independent of renal function, a secondary analysis of the ARISTOTLE trial showed.
MedPage Today  Aug 26  Comment 
PARIS (MedPage Today) -- The ARISTOTLE trial pitting the novel anticoagulant apixaban against warfarin for preventing stroke in patients with atrial fibrillation looks like it will be the stand-out of this year's meeting of the European Society of...
Forbes  Jun 22  Comment 
Pfizer and Bristol-Myers Squibb said today that their new oral direct Factor Xa drug apixaban, which will be marketed under the brand name of Eliquis, had met the primary endpoint of the ARISTOTLE study.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki